Free Trial
→ Elon's next millionaires start October 24? (From Behind the Markets) (Ad)tc pixel Free CRMD Stock Alerts

CorMedix (CRMD) Short Interest Ratio & Short Volume

CorMedix logo
$7.32 +0.04 (+0.55%)
Closing price 04:00 PM Eastern
Extended Trading
$7.34 +0.02 (+0.27%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

CorMedix Short Interest Overview

As of September 15, 2026, CorMedix (CRMD) had a short interest of 16.20 million shares sold short, representing 21.54% of the public float. This marks a 1.06% increase in short interest since the prior report. The short interest ratio (days to cover) is 18.5, meaning it would take 18.5 days of the average trading volume of 1.59 million shares to cover all short positions.

Current Short Interest
16,202,272 shares
Previous Short Interest
16,032,112 shares
Change Vs. Previous Month
1.06%
Dollar Volume Sold Short
$125.73 million
Short Interest Ratio
18.5 Days to Cover
Last Record Date
September 15, 2026
Outstanding Shares
77,940,000 shares
Short Percent of Float
21.54%
Today's Trading Volume
1,018,307 shares
Average Trading Volume
1,589,997 shares
Today's Volume Vs. Average
64%
Short Selling CorMedix?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for CorMedix and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

CRMD Short Interest Over Time

CRMD Days to Cover Over Time

CRMD Percentage of Float Shorted Over Time

CorMedix Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/202616,202,272 shares $125.73 million +1.1%21.5%18.49 $7.76
8/31/202616,032,112 shares $132.43 million -6.5%21.3%12.98 $8.26
8/14/202617,149,908 shares $129.31 million +5.3%22.8%11.05 $7.54
7/31/202616,283,087 shares $122.61 million +6.1%21.5%17.1 $7.53
7/15/202615,349,811 shares $129.25 million +2.8%20.3%17.01 $8.42
6/30/202614,930,822 shares $117.21 million +2.9%19.7%7.75 $7.85
6/15/202614,505,152 shares $124.60 million -0.3%19.2%11.91 $8.59
5/29/202614,551,054 shares $122.81 million -6.4%19.2%10.92 $8.44
5/15/202615,541,297 shares $117.34 million -4.2%20.5%10.67 $7.55
4/30/202616,222,947 shares $123.13 million +3.2%21.4%16.64 $7.59
4/15/202615,719,495 shares $113.65 million -0.4%20.8%15.89 $7.23
3/31/202615,782,505 shares $107.16 million -0.4%20.8%11.93 $6.79
3/13/202615,846,435 shares $102.21 million -4.6%20.9%7.93 $6.45
2/27/202616,618,186 shares $118.49 million -1.7%22.0%14.55 $7.13
2/13/202616,896,431 shares $124.02 million +3.4%22.3%8.66 $7.34
1/30/202616,339,585 shares $126.80 million -8.7%21.6%6.38 $7.76
1/15/202617,892,607 shares $125.43 million +7.1%23.6%3.13 $7.01
12/31/202516,701,569 shares $194.24 million -1.0%22.1%7.34 $11.63
12/15/202516,875,402 shares $191.20 million -1.2%22.3%5.51 $11.33
11/28/202517,080,635 shares $167.13 million -2.1%22.6%6.26 $9.79
11/14/202517,445,325 shares $196.09 million +5.1%23.5%4.95 $11.24
10/31/202516,599,216 shares $184.75 million +2.6%22.4%6.06 $11.13
10/15/202516,180,000 shares $171.67 million +4.0%21.9%4.8 $10.61
9/30/202515,560,000 shares $180.96 million -6.7%N/A4.7 $11.63
9/15/202516,670,000 shares $210.88 million +40.2%N/A4.9 $12.65
8/31/202511,890,000 shares $176.33 million -16.2%16.8%3.7 $14.83
8/15/202514,180,000 shares $183.35 million +32.8%N/A5.8 $12.93
7/31/202510,680,000 shares $124.64 million +6.3%15.1%4.6 $11.67
7/15/202510,050,000 shares $114.27 million +4.2%N/A4.9 $11.37
6/30/20259,650,000 shares $118.89 million +12.3%15.0%4.8 $12.32
6/15/20258,590,000 shares $125.07 million +0.7%13.4%4 $14.56
5/31/20258,530,000 shares $102.96 million +1.0%14.8%4.4 $12.07
5/15/20258,450,000 shares $98.78 million +5.1%14.7%4.6 $11.69
4/30/20258,040,000 shares $73.89 million -2.7%N/A4.6 $9.19
4/15/20258,260,000 shares $61.12 million +4.3%14.4%5.8 $7.40
3/31/20257,920,000 shares $48.79 million -3.2%13.8%5.3 $6.16
3/15/20258,180,000 shares $85.64 million +3.8%14.2%6.3 $10.47
2/28/20257,880,000 shares $81.64 million +6.6%13.7%7.7 $10.36
2/15/20257,390,000 shares $77.45 million +2.9%12.8%7.2 $10.48
1/31/20257,180,000 shares $73.74 million +1.4%N/A6.6 $10.27
Champion stock-picker warns, “Watch out for the Anthropic IPO” (Ad)

Matt McCall flagged AMD back in 2009, before it rose 25,000 percent, turning a 5,000 dollar stake into more than 1.28 million dollars. Now he's focused on Anthropic's IPO, with a twist: his latest pick isn't the company itself but a stock he says could benefit from the hype. McCall is sharing the name and ticker free of charge.tc pixel

Get Matt McCall's free Anthropic-linked stock pick now
1/15/20257,080,000 shares $84.25 million +1.1%N/A5.5 $11.90
12/31/20247,000,000 shares $56.70 million +4.0%N/A5.6 $8.10
12/15/20246,730,000 shares $56.40 million -2.3%N/A5.8 $8.38
11/30/20246,890,000 shares $67.94 million +0.7%N/A5.8 $9.86
11/15/20246,840,000 shares $70.66 million +8.9%N/A5.8 $10.33
10/31/20246,280,000 shares $63.15 million -20.1%N/A5.4 $10.06
10/15/20247,860,000 shares $79.31 million -15.2%N/A8.7 $10.09
9/30/20249,270,000 shares $74.90 million -10.7%N/A11.4 $8.08
9/15/202410,380,000 shares $72.14 million +2.7%N/A14.7 $6.95
8/31/202410,110,000 shares $63.09 million -2.0%N/A15.6 $6.24
8/15/202410,320,000 shares $49.48 million +1.2%N/A18.9 $4.80
7/31/202410,200,000 shares $46.72 million -1.5%N/A20.2 $4.58
7/15/202410,360,000 shares $50.76 million +5.6%N/A19.5 $4.90
6/30/20249,810,000 shares $42.48 million -1.6%N/A15.3 $4.33
6/15/20249,970,000 shares $47.06 million +1.4%N/A15.6 $4.72
5/31/20249,830,000 shares $51.80 million +1.6%N/A14.6 $5.27
5/15/20249,680,000 shares $50.82 million -1.8%N/A14.9 $5.25
4/30/20249,860,000 shares $51.81 million +5.1%N/A16.1 $5.26
4/15/20249,380,000 shares $50.46 million +13.7%N/A16 $5.38
3/31/20248,250,000 shares $34.98 million +6.2%N/A18.6 $4.24
3/15/20247,770,000 shares $29.60 million +0.7%N/A17.7 $3.81
2/29/20247,720,000 shares $27.33 million -0.1%N/A17.9 $3.54
2/15/20247,730,000 shares $25.28 million +7.5%N/A16.4 $3.27
1/31/20247,190,000 shares $21.21 million +2.0%N/A8.6 $2.95
1/15/20247,050,000 shares $24.46 million -0.6%N/A8.4 $3.47
12/31/20237,090,000 shares $26.66 million -1.5%N/A8.3 $3.76
12/15/20237,200,000 shares $23.83 million -8.1%N/A8.5 $3.31
11/30/20237,830,000 shares $25.45 million +17.6%N/A9.3 $3.25
11/15/20236,660,000 shares $22.18 million +17.1%N/A8.1 $3.33
10/31/20235,690,000 shares $19.80 million +11.4%N/A12.1 $3.48
10/15/20235,110,000 shares $17.07 million +3.0%N/A10.8 $3.34
9/30/20234,960,000 shares $18.35 million +6.4%N/A9.8 $3.70
9/15/20234,660,000 shares $18.22 million +15.4%N/A6.2 $3.91
8/31/20234,040,000 shares $16.44 million +0.3%N/A5.2 $4.07
8/15/20234,030,000 shares $17.17 million -7.6%N/A5.5 $4.26
7/31/20234,360,000 shares $19.27 million -16.3%N/A5.8 $4.42
7/15/20235,210,000 shares $20.27 million -0.2%N/A7.5 $3.89
6/30/20235,220,000 shares $20.70 million +71.7%N/A7.9 $3.97
6/15/20233,040,000 shares $15.72 million +16.0%N/A6.2 $5.17
5/31/20232,620,000 shares $12.60 million +20.7%N/A8.4 $4.81
5/15/20232,170,000 shares $11.18 million -2.3%N/A7 $5.15
4/30/20232,220,000 shares $10.97 million +8.3%N/A8.6 $4.94
4/15/20232,050,000 shares $10.80 million +3.0%N/A8.4 $5.27
3/31/20231,990,000 shares $8.24 million +19.2%N/A8.2 $4.14
3/15/20231,670,000 shares $5.90 million +4.4%N/A7.5 $3.53
2/28/20231,600,000 shares $6.48 million -0.6%N/A7.1 $4.05
2/15/20231,610,000 shares $7.23 million -3.0%N/A7.3 $4.49
1/31/20231,660,000 shares $7.20 million +1.2%N/A6.7 $4.34
1/15/20231,640,000 shares $7.27 million +6.5%N/A7 $4.43
12/30/20221,540,000 shares $6.50 million No ChangeN/A7.2 $4.22
"The largest market in human history" (Ad)

SpaceX quietly filed paperwork describing what it calls the largest actionable total addressable market in human history, valued at 28.5 trillion dollars. Former Wall Street CEO Dylan says the opportunity has nothing to do with the SpaceX IPO, self-driving cars, or robotics. Instead, it centers on an obscure AI firm Elon has reportedly been paying since 2012.tc pixel

See the AI stock behind Elon's 28.5 trillion dollar plan now
12/15/20221,540,000 shares $6.38 million -1.3%N/A8 $4.14
11/30/20221,560,000 shares $6.49 million -4.9%N/A7.9 $4.16
11/15/20221,640,000 shares $6.05 million No ChangeN/A8.5 $3.69
10/31/20221,640,000 shares $5.03 million +5.1%N/A5.2 $3.07
10/15/20221,560,000 shares $4.60 million -5.5%N/A4.1 $2.95
9/30/20221,650,000 shares $4.67 million +1.9%N/A4 $2.83
9/15/20221,620,000 shares $5.65 million -5.3%N/A3.1 $3.49
8/31/20221,710,000 shares $6.04 million -5.0%N/A3.1 $3.53

CRMD Short Interest - Frequently Asked Questions

Short interest is the volume of CorMedix shares that have been sold short but have not yet been closed out or covered. As of September 15th, investors have sold 16,202,272 shares of CRMD short. 21.54% of CorMedix's shares are currently sold short. Learn More on CorMedix's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRMD shares currently have a short interest ratio of 18.5. Learn More on CorMedix's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 21.54% of CorMedix's floating shares are currently sold short.

CorMedix saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 16,202,272 shares, an increase of 1.1% from the previous total of 16,032,112 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

21.54% of CorMedix's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceuticals" compare to CorMedix: HUTCHMED (China) Limited Sponsored ADR (0.14%), Harmony Biosciences Holdings, Inc. (8.93%), Trulieve Cannabis Corp. (2.76%), Mineralys Therapeutics, Inc. (12.81%), Prestige Consumer Healthcare Inc. (10.27%), Perrigo Company plc (16.38%), Bausch Health Cos Inc. (2.91%), Ocular Therapeutix, Inc. (14.07%), Trevi Therapeutics, Inc. (10.01%), Urogen Pharma (13.43%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($75.21 billion), Invesco QQQ ($46.31 billion), iShares Russell 2000 ETF ($27.98 billion), SPDR S&P Biotech ETF ($11.59 billion), Nebius Group N.V. ($9.70 billion), Canadian Natural Resources Limited ($9.42 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($8.53 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.79 billion), and Financial Select Sector SPDR Fund ($7.74 billion). View all of the most shorted stocks.

Short selling CRMD is an investing strategy that aims to generate trading profit from CorMedix as its price is falling. CRMD shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for CorMedix occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CRMD, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRMD, twice per month. The most recent reporting period available is September, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like CRMD:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:CRMD is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 9/24/2026. FINRA publishes updated short interest twice a month.
From Our Partners
A dividend every week of the year
Most dividend stocks pay quarterly, leaving long stretches of silence between paydays. For investors covering ...
Market Savvy | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Elon's next millionaires start October 24?
SpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into milliona...
Behind the Markets | Sponsoredtc pixel
The national debt just passed $39 trillion
The U.S. national debt just topped $39 trillion, up nearly $3 trillion in a single year and on pace to hit $40...
US Gold Bureau | Sponsoredtc pixel
Analyst nicknamed “The Prophet” issues new warning for America
Whitney Tilson exposed a major company on 60 Minutes in an Emmy-winning investigation - the stock lost nearly ...
Stansberry Research | Sponsoredtc pixel
Inside the Options Play With a High Historical Win Rate
Ian Cooper's newest strategy targets triple-digit returns in just 9 days. It doesn't work every time, but a 73...
TradeWins | Sponsoredtc pixel
These gold assets are priced for $1,800 gold [it's over $4,000]
Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...
Golden Portfolio | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel